Live Breaking News & Updates on Harbor Advisors|Page 11

Stay updated with breaking news from Harbor advisors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Stevens Capital Management LP Cuts Stock Position in MSCI Inc. (NYSE:MSCI)

Stevens Capital Management LP lessened its stake in MSCI Inc. (NYSE:MSCI – Free Report) by 23.7% during the 4th quarter, Holdings Channel.com reports. The firm owned 1,433 shares of the technology company’s stock after selling 444 shares during the quarter. Stevens Capital Management LP’s holdings in MSCI were worth $811,000 as of its most recent […] ....

Czech Republic , Raymond James , Czech National Bank , Exchange Traded Concepts , Holdings Channel , Deutsche Bank Aktiengesellschaft , Flagship Harbor Advisors , Royal Bank , Ronald Blue Trust Inc , Caprock Group , Morgan Stanley , Stevens Capital Management , Free Report , Capital Management , Blue Trust , Harbor Advisors , Traded Concepts , National Bank , Get Free Report , Visit Holdingschannel , Nyse Msci , Computer And Technology , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Cidara Therapeutics (NASDAQ:CDTX) Shares Gap Up on Analyst Upgrade

Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) gapped up prior to trading on Thursday after Needham & Company LLC raised their price target on the stock from $3.00 to $25.00. The stock had previously closed at $12.29, but opened at $14.50. Needham & Company LLC currently has a buy rating on the […] ....

United States , Raymond James Financial Services Advisors Inc , Needham Company , Cidara Therapeutics Company Profile , Flagship Harbor Advisors , Cantor Fitzgerald , Cidara Therapeutics Inc , Cidara Therapeutics , Get Free Report , Harbor Advisors , James Financial Services Advisors , Pale Fire Capital , Cidara Therapeutics Daily , Nasdaq Cdtx ,

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Given Consensus Rating of "Buy" by Brokerages

Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have received a consensus recommendation of “Buy” from the four analysts that are presently covering the company, MarketBeat reports. Three analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average twelve-month price target […] ....

United States , Flagship Harbor Advisors , Cidara Therapeutics Inc , Needham Company , Raymond James Financial Services Advisors Inc , Cantor Fitzgerald , Cidara Therapeutics , Get Free Report , James Financial Services Advisors , Harbor Advisors , Pale Fire Capital , Get Free , Cidara Therapeutics Daily , Nasdaq Cdtx ,